This article is more than 5 years old. Information may no longer be current.
Mitomycin can be used during deep sclerectomy
Click Here to Manage Email Alerts
SAN FRANCISCO — Mitomycin-C can be safely used to augment deep sclerectomy with collagen wick implantation for high-risk glaucoma patients, according to a surgeon speaking here.
Iqbal K. Ahmed, MD, evaluated the use of mitomycin during the procedure in 57 eyes of 53 patients at risk for filtration surgery failure. He presented his results here at the American Glaucoma Society meeting.
Intraocular pressure, which averaged 32.67 mm Hg preoperatively, was reduced to an average 12.8 mm Hg postoperatively. Surgical success was defined as a reduction of more that 30% in preoperative IOP or a reduction to less than 18 mm Hg without additional medications.
Complete success was noted in 52 eyes (91.2%), and 53 eyes (93%) had diffuse, posterior noncystic blebs. There were no cases of flat anterior chambers and no significant choroidal effusions. One eye (1.8%) required intervention for hypotony, and two eyes (3.5%) required laser treatment for iris incarceration.